查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726195

脂質奈米顆粒市場規模、佔有率、趨勢分析報告：按脂質奈米顆粒、分子、應用、適應症、最終用途、地區、細分市場、預測，2025-2030 年

Lipid Nanoparticle Market Size, Share & Trends Analysis Report By LNP (Liposomes, Nanostructured Lipid Carriers), By Molecule (mRNA, siRNA), By Application, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

脂質奈米顆粒市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球脂質奈米顆粒市場預計到 2030 年將達到 15.4 億美元，預測期內的複合年成長率為 13.64%。

由於對先進藥物傳遞系統的需求不斷增加，脂質市場正在經歷顯著成長，尤其是在基因治療、腫瘤學和疫苗等領域。 LNP 描述了一種高效方法，可以封裝和遞送多種治療分子（包括 mRNA、siRNA 和小分子），將其直接遞送至目標細胞，同時提高穩定性並減少分解。公共和私人公司對奈米醫學的研發活動激增和投資不斷增加，在支持製藥和生物技術領域廣泛採用基於 LNP 的藥物製劑方面發揮關鍵作用。

在疫情期間，利用基於 LNP 的 mRNA 疫苗遞送系統開發 COVID-19 疫苗引起了大量關注和資源。人們對疫苗輸送技術的日益關注推動了 LNP 配方和製造能力的創新和投資，間接使市場受益。監管機構加快了 COVID-19 治療和疫苗的審查和核准流程，其中包括利用 LNP 技術的治療和疫苗。雖然這促進了 COVID-19 治療藥物的快速進入市場，但也凸顯了簡化其他治療領域基於 LNP 的產品的監管途徑和標準的必要性，這可能會影響未來的法律規範和市場動態。

此外，策略合作、脂質製劑的技術進步以及對精準醫療的認知不斷提高繼續推動市場成長。該公司目前正在投資下一代 LNP 平台，旨在實現定向投放、降低毒性並提高有效載荷的多功能性。可電離脂質、脂質-聚合物混合系統和表面改質等創新正在擴大 LNP 在治療複雜疾病（包括罕見遺傳疾病）方面的範圍。這些發展，加上有利的監管環境和日益成長的個人化治療需求，預計將在未來幾年保持強勁的市場勢頭。

脂質奈米顆粒市場報告重點

  • 以 LNP 計算，脂質體領域在 2024 年佔據了整個市場的主導地位，收益佔有率最大。脂質體藥物的監管核准及其在化妝品和營養保健品應用中的不斷擴大，繼續支持市場成長。
  • 以分子計算，mRNA 部分預計將在 2024 年佔據整個市場的最大收益佔有率，並在預測期內以最快的複合年成長率成長。隨著製藥和生物技術公司增加對 mRNA 療法的投資，對最佳化 LNP 輸送系統的需求持續上升，從而推動市場成長。
  • 2024年，醫療應用領域佔據主導地位。這是由於研究機構和工業參與企業在藥物開發方面的合作增加，以及政府資金增加。
  • 預計到 2024 年，腫瘤學將佔據適應症領域的主導地位，並在預測期內實現顯著的複合年成長率。癌症負擔的不斷加重以及 LNP 在癌症治療中的潛力正在推動該領域的重大研究和發展。
  • 預計製藥和生物技術公司將主導最終用途領域，而學術和研究機構領域預計將在預測期內實現最快的複合年成長率。
  • 由於感染疾病負擔高、購買力平價高、政府對優質醫療的支持以及報銷的可用性等因素，北美將在 2024 年佔據市場主導地位。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 依因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 波特五力分析
    • COVID-19影響分析

4. 脂質奈米顆粒市場：LNP 業務分析

  • 細分儀表板
  • 脂質奈米粒子的全域變異性分析
  • 全球脂質奈米顆粒市場規模與趨勢分析（LNP，2018-2030）
  • 脂質體
  • 固體脂質奈米顆粒
  • 奈米結構脂質載體
  • 其他

5. 脂質奈米顆粒市場：分子業務分析

  • 細分儀表板
  • 脂質奈米粒子的全域變異性分析
  • 全球脂質奈米顆粒市場規模及趨勢分析（按分子，2018-2030 年）
  • siRNA
  • mRNA
  • 其他

6. 脂質奈米顆粒市場：應用商業分析

  • 細分儀表板
  • 脂質奈米粒子的全域變異性分析
  • 全球脂質奈米顆粒市場規模及趨勢分析（依應用，2018-2030）
  • 治療
  • 研究

7. 脂質奈米顆粒市場：適應症業務分析

  • 細分儀表板
  • 脂質奈米粒子的全域變異性分析
  • 全球脂質奈米顆粒市場規模及趨勢分析（2018-2030）
  • 癌症
  • 感染疾病
  • 血液系統疾病
  • 其他

8. 脂質奈米顆粒市場-最終用途業務分析

  • 細分儀表板
  • 脂質奈米粒子的全域變異性分析
  • 全球脂質奈米顆粒市場規模及最終用途趨勢分析（2018-2030）
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

第9章脂質奈米顆粒市場：LNP、分子、應用、適應症、最終用途、區域、估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年公司地位分析
  • 公司簡介/上市公司
    • Merck KGaA
    • Evonik Industries AG
    • Gattefosse
    • FUJIFILM Pharmaceutical
    • Danaher（Precision NanoSystems）
    • Creative Biolabs
    • IOI Oleo GmbH
    • NOF Corporation
    • Lipoid GmbH
    • Cyman Chemical
Product Code: GVR-4-68040-547-5

Lipid Nanoparticle Market Growth & Trends:

The global lipid nanoparticle market is anticipated to reach USD 1.54 billion by 2030 and is projected to grow at a CAGR of 13.64% during the forecast period, according to a new report by Grand View Research, Inc. The lipid market has experienced significant growth driven by increasing demand for advanced drug delivery systems, particularly in the fields of gene therapy, oncology, and vaccines. LNPs offer a highly efficient method for encapsulating and delivering a wide range of therapeutic molecules-including mRNA, siRNA, and small molecules-directly to target cells with improved stability and reduced degradation. The surge in R&D activities and growing investment in nanomedicine by both public institutions and private players have played a critical role in supporting the widespread adoption of LNP-based drug formulations across the pharmaceutical and biotechnology sectors.

The development of COVID-19 vaccines that utilized LNP-based delivery systems for mRNA vaccines garnered significant attention and resources during the pandemic. This increased focus on vaccine delivery technologies has indirectly benefited the market by driving innovation and investment in LNP formulation and manufacturing capabilities. Regulatory agencies expedited the review and approval processes for COVID-19 therapeutics and vaccines, including those utilizing LNP technology. While this facilitated rapid market entry for COVID-19 treatments, it also underscored the need for streamlined regulatory pathways and standards for LNP-based products in other therapeutic areas, potentially shaping future regulatory frameworks and market dynamics.

Moreover, strategic collaborations, technological advancements in lipid formulation, and increased awareness of precision medicine continue to drive market growth. Companies are now investing in next-generation LNP platforms designed for targeted delivery, lower toxicity, and enhanced payload versatility. Innovations such as ionizable lipids, hybrid lipid-polymer systems, and surface modifications are expanding the scope of LNPs in treating complex diseases, including rare genetic disorders. These developments, coupled with a favorable regulatory landscape and rising demand for personalized treatments, are expected to sustain strong momentum in the market over the coming years.

Lipid Nanoparticle Market Report Highlights:

  • Based on LNP, the liposomes segment dominated the overall market with the largest revenue share in 2024. Regulatory approvals of liposome-based drugs and their expanding use in cosmetic and nutraceutical applications continue to support market growth.
  • In terms of molecule, the mRNA segment dominated the overall market with the largest revenue share in 2024 and is expected to grow at the fastest CAGR during the forecast period. As pharmaceutical companies and biotech firms increasingly invest in mRNA therapeutics, the demand for optimized LNP delivery systems continues to rise, fueling market growth.
  • Therapeutics dominated the application segment in 2024 owing to the increasing collaborations between research institutions and industry players for drug development and growing government funding,
  • In 2024, cancer dominated the disease indication segment and is expected to witness a significant CAGR over the forecast period. The rising cancer burden and the potential of LNPs in cancer treatment are driving significant research and development efforts in this area.
  • Pharmaceutical & biotechnology companies dominated the end use segment and the academic & research institute segment is expected to register the fastest CAGR during the forecast period.
  • North America dominated the market in 2024 owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. LNP
    • 1.2.2. Molecule
    • 1.2.3. Application
    • 1.2.4. Indication
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Growing Demand for Drug Delivery Systems
      • 3.3.1.2. Rise in Pharmaceutical Research and Development
      • 3.3.1.3. Increasing Focus on Nanotechnology
      • 3.3.1.4. Government Support and Funding for RNA-based therapies
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Development Costs
      • 3.3.2.2. Stringent Regulations Related to Approval and Commercialization
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Lipid Nanoparticle Market: LNP Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Lipid Nanoparticle Movement Analysis
  • 4.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by LNP, 2018 to 2030 (USD Million)
  • 4.4. Liposomes
    • 4.4.1. Global Liposomes Market, 2018 - 2030 (USD Million)
  • 4.5. Solid Lipid Nanoparticles
    • 4.5.1. Global Solid Lipid Nanoparticles Market, 2018 - 2030 (USD Million)
  • 4.6. Nanostructured Lipid Carriers
    • 4.6.1. Global Nanostructured Lipid Carriers Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 5. Lipid Nanoparticle Market: Molecule Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Lipid Nanoparticle Movement Analysis
  • 5.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
  • 5.4. siRNA
    • 5.4.1. Global siRNA Market, 2018 - 2030 (USD Million)
  • 5.5. mRNA
    • 5.5.1. Global mRNA Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Lipid Nanoparticle Market: Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Lipid Nanoparticle Movement Analysis
  • 6.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Therapeutics
    • 6.4.1. Global Therapeutics Market, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Global Research Market, 2018 - 2030 (USD Million)

Chapter 7. Lipid Nanoparticle Market: Indication Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Lipid Nanoparticle Movement Analysis
  • 7.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 7.4. Cancer
    • 7.4.1. Global Cancer Market, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.6. Blood Diseases
    • 7.6.1. Global Blood Diseases Market, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 8. Lipid Nanoparticle Market: End Use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Lipid Nanoparticle Movement Analysis
  • 8.3. Global Lipid Nanoparticle Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 8.5. Academic & Research Institutes
    • 8.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 9. Lipid Nanoparticle Market: Regional Estimates & Trend Analysis by LNP, Molecule, Application, Indication, & End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Target Disease Prevalence
      • 9.3.2.4. Regulatory Framework
      • 9.3.2.5. U.S. Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Target Disease Prevalence
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Canada Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Target Disease Prevalence
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Mexico Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Target Disease Prevalence
      • 9.4.2.4. Regulatory Framework
      • 9.4.2.5. UK Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Target Disease Prevalence
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Germany Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Target Disease Prevalence
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. France Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Target Disease Prevalence
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Italy Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Target Disease Prevalence
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Spain Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Target Disease Prevalence
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Denmark Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Target Disease Prevalence
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Sweden Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Target Disease Prevalence
      • 9.4.9.4. Regulatory Framework
      • 9.4.9.5. Norway Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Target Disease Prevalence
      • 9.5.2.4. Regulatory Framework
      • 9.5.2.5. Japan Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Target Disease Prevalence
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. China Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Target Disease Prevalence
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. India Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Target Disease Prevalence
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Australia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Target Disease Prevalence
      • 9.5.6.4. Regulatory Framework
      • 9.5.6.5. Thailand Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Target Disease Prevalence
      • 9.5.7.4. Regulatory Framework
      • 9.5.7.5. South Korea Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Target Disease Prevalence
      • 9.6.2.4. Regulatory Framework
      • 9.6.2.5. Brazil Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Target Disease Prevalence
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Argentina Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Target Disease Prevalence
      • 9.7.2.4. Regulatory Framework
      • 9.7.2.5. South Africa Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Target Disease Prevalence
      • 9.7.3.4. Regulatory Framework
      • 9.7.3.5. Saudi Arabia Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Target Disease Prevalence
      • 9.7.4.4. Regulatory Framework
      • 9.7.4.5. UAE Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Target Disease Prevalence
      • 9.7.5.4. Regulatory Framework
      • 9.7.5.5. Kuwait Lipid nanoparticle market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Evonik Industries AG
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Gattefosse
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. FUJIFILM Pharmaceutical
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Danaher (Precision NanoSystems)
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Creative Biolabs
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. IOI Oleo GmbH
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. NOF Corporation
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Lipoid GmbH
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Cyman Chemical
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 4 Global lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 6 Global lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 7 Global lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Global lipid nanoparticle market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 11 North America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 13 North America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 14 North America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 15 U.S. lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 16 U.S. lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 17 U.S. lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 18 U.S. lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 19 U.S. lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Canada lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 21 Canada lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 22 Canada lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 23 Canada lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Canada lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Mexico lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 26 Mexico lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 27 Mexico lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 28 Mexico lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Mexico lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Europe lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 31 Europe lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 32 Europe lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 33 Europe lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 34 Europe lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 35 Europe lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 36 UK lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 37 UK lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 38 UK lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 39 UK lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 40 UK lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Germany lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 42 Germany lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 43 Germany lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 44 Germany lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 45 Germany lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 46 France lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 47 France lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 48 France lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 49 France lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 50 France lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Italy lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 52 Italy lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 53 Italy lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 54 Italy lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 55 Italy lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Spain lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 57 Spain lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 58 Spain lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 59 Spain lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 60 Spain lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Denmark lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 62 Denmark lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 63 Denmark lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 64 Denmark lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 65 Denmark lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Sweden lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 67 Sweden lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 68 Sweden lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 69 Sweden lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Sweden lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Norway lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 72 Norway lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 73 Norway lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 74 Norway lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Norway lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Japan lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 83 Japan lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 84 Japan lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 85 Japan lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 86 Japan lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 87 China lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 88 China lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 89 China lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 90 China lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 91 China lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 92 India lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 93 India lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 94 India lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 95 India lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 96 India lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Australia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 98 Australia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 99 Australia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 100 Australia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 101 Australia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Thailand lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 103 Thailand lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 104 Thailand lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 105 Thailand lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 106 Thailand lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 107 South Korea lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 108 South Korea lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 109 South Korea lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 110 South Korea lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 111 South Korea lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Latin America lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 113 Latin America lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 114 Latin America lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 115 Latin America lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 116 Latin America lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 117 Latin America lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 118 Brazil lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 119 Brazil lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 120 Brazil lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 121 Brazil lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 122 Brazil lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 123 Argentina lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 124 Argentina lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 125 Argentina lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 126 Argentina lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 127 Argentina lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa lipid nanoparticle market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 134 South Africa lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 135 South Africa lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 136 South Africa lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 137 South Africa lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 138 South Africa lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 144 UAE lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 145 UAE lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 146 UAE lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 147 UAE lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 148 UAE lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait lipid nanoparticle market, by LNP, 2018 - 2030 (USD Million)
  • Table 150 Kuwait lipid nanoparticle market, by application, 2018 - 2030 (USD Million)
  • Table 151 Kuwait lipid nanoparticle market, by molecule, 2018 - 2030 (USD Million)
  • Table 152 Kuwait lipid nanoparticle market, by indication, 2018 - 2030 (USD Million)
  • Table 153 Kuwait lipid nanoparticle market, by end use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Lipid nanoparticle market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Genomics - Industry value chain analysis
  • Fig. 15 Lipid nanoparticle market driver analysis
  • Fig. 16 Lipid nanoparticle market restraint analysis
  • Fig. 17 Lipid nanoparticle market: Porter's analysis
  • Fig. 18 Lipid nanoparticle market: LNP outlook and key takeaways
  • Fig. 19 Lipid nanoparticle market: LNP market share analysis, 2023 - 2030
  • Fig. 20 Global lipid nanoparticle by liposomes market, 2018 - 2030 (USD Million)
  • Fig. 21 Global lipid nanoparticle by solid lipid nanoparticles market, 2018 - 2030 (USD Million)
  • Fig. 22 Global lipid nanoparticle by nanostructured lipid carriers market, 2018 - 2030 (USD Million)
  • Fig. 23 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 24 Lipid nanoparticle market: Molecule outlook and key takeaways
  • Fig. 25 Lipid nanoparticle market: Molecule market share analysis, 2023-2030
  • Fig. 26 Global lipid nanoparticle by siRNA market, 2018 - 2030 (USD Million)
  • Fig. 27 Global lipid nanoparticle by mRNA market, 2018 - 2030 (USD Million)
  • Fig. 28 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 29 Lipid nanoparticle market: Application outlook and key takeaways
  • Fig. 30 Lipid nanoparticle market: Application market share analysis, 2023-2030
  • Fig. 31 Global lipid nanoparticle by therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 32 Global lipid nanoparticle by research market, 2018 - 2030 (USD Million)
  • Fig. 33 Lipid nanoparticle market: Indication outlook and key takeaways
  • Fig. 34 Lipid nanoparticle market: Indication market share analysis, 2023-2030
  • Fig. 35 Global lipid nanoparticle by cancer market, 2018 - 2030 (USD Million)
  • Fig. 36 Global lipid nanoparticle by infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 37 Global lipid nanoparticle by blood diseases market, 2018 - 2030 (USD Million)
  • Fig. 38 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 39 Lipid nanoparticle market: End user outlook and key takeaways
  • Fig. 40 Lipid nanoparticle market: end user market share analysis, 2023-2030
  • Fig. 41 Global lipid nanoparticle by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 42 Global lipid nanoparticle by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 43 Global lipid nanoparticle by others market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. key country dynamics
  • Fig. 47 U.S. lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada key country dynamics
  • Fig. 49 Canada lipid nanoparticle market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico key country dynamics
  • Fig. 51 Mexico lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 52 Europe lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 69 Asia-Pacific lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 70 Japan key country dynamics
  • Fig. 71 Japan lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 82 Latin America lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 85 Argentina key country dynamics
  • Fig. 86 Argentina lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 87 MEA lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 88 South Africa key country dynamics
  • Fig. 89 South Africa lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 90 Saudi Arabia key country dynamics
  • Fig. 91 Saudi Arabia lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 92 UAE key country dynamics
  • Fig. 93 UAE lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 94 Kuwait key country dynamics
  • Fig. 95 Kuwait lipid nanoparticle market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 96 Key company categorization
  • Fig. 97 Company market positioning
  • Fig. 98 Market participant categorization
  • Fig. 99 Strategy framework